Abstracts
Résumé
Les défenses immunitaires de l’organisme vis-à-vis des agents pathogènes et des cellules malignes reposent en grande partie sur la surveillance par les lymphocytes T cytotoxiques. Cette surveillance est rendue possible par un système d’apprêtement (processing) des protéines cellulaires, qui fournit des échantillons peptidiques aux molécules de classe I exprimées à la surface cellulaire. Pour produire en permanence une gamme de peptides représentative du monde des protéines fabriquées par la cellule, de façon fidèle et quasiment en temps réel, ce système exploite des voies fondamentales du métabolisme cellulaire, auquel il associe certains acteurs ayant une fonction plus spécialisée. Ainsi, un élément clef du métabolisme des protéines cellulaires, le protéasome, principale protéase du cytosol, est exploitée comme source de peptides, en prélevant une petite fraction de peptides pour la surveillance immunitaire. Ce sont les différentes étapes requises pour associer ces peptides aux molécules de classe I du CMH (complexe majeur d’histocompatibilité) qui sont discutées dans cet article.
Summary
The immune defences of our organism against pathogens and malignant transformation rely to a large extent on surveillance by cytotoxic T lymphocytes. This surveillance in turn depends on the antigen processing system, which provides peptide samples of the cellular protein composition to MHC (major histocompatibility complex) class I molecules displayed on the cell surface. To continuously and almost in real time provide a representative sample of the array of proteins synthesized by the cell, this system exploits some fundamental pathways of the cellular metabolism, with the help of several dedicated players acting exclusively in antigen processing. Thus, a key element in the turnover of cellular proteins, protein degradation by cytosolic proteasome complexes, is exploited as source of peptides, by recruiting a minor fraction of the produced peptides as ligands for MHC class I molecules. These peptides can be further processed and adapted to the precise binding requirements of allelic MHC class I molecules by enzymes in the cytosol and endoplasmic reticulum. The latter compartment is equipped with several dedicated players helping peptide assembly with class I molecules. These include the TAP (transporter associated with antigen processing) membrane transporter pumping peptides into the ER, and tapasin, a chaperone with a structure similar to MHC molecules that tethers class I molecules awaiting peptide loading to the TAP transporter, and mediates optimization of MHC class I ligand by a still somewhat mysterious mechanism. Additional “house-keeping” chaperones that are known to act in concert in ER quality control, assist and control correct folding, oxidation and assembly of MHC class I molecules. While this processing system handles exclusively endogenous cellular proteins in most cells, dendritic cells employ one or several special pathways to shuttle exogenous, internalized proteins into the system, in a process referred to as cross-presentation. Deciphering the cell biological mechanism creating the link between the endosomal and secretory pathways that enables cross-presentation is one of the challenges faced by contemporary research in the field of MHC class I antigen processing.
Appendices
Références
- 1. Janeway C. Immunobiology : the immune system in health and disease, 6th ed. New York : Garland Science, 2005.
- 2. Shastri N, Schwab S, Serwold T. Producing nature’s gene-chips : the generation of peptides for display by MHC class I molecules. Annu Rev Immunol 2002 ; 20 : 463-93.
- 3. Saveanu L, Carroll O, Hassainya Y, van Endert P. Complexity, contradictions, and conundrums : studying post-proteasomal proteolysis in HLA class I antigen presentation. Immunol Rev 2005 ; 207 : 42-59.
- 4. Wilson NS, Villadangos JA. Regulation of antigen presentation and cross-presentation in the dendritic cell network : facts, hypothesis, and immunological implications. Adv Immunol 2005 ; 86 : 241-305.
- 5. Ciechanover A. Proteolysis : from the lysosome to ubiquitin and the proteasome. Nat Rev Mol Cell Biol 2005 ; 6 : 79-87.
- 6. Baumeister W, Walz J, Zuhl F, Seemuller E. The proteasome : paradigm of a self-compartmentalizing protease. Cell 1998 ; 92 : 367-80.
- 7. Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD : the long road to destruction. Nat Cell Biol 2005 ; 7 : 766-72.
- 8. Yewdell J. To DRiP or not to DRiP : generating peptide ligands for MHC class I molecules from biosynthesized proteins. Mol Immunol 2002 ; 39 : 139-46.
- 9. Vabulas RM, Hartl FU. Protein synthesis upon acute nutrient restriction relies on proteasome function. Science 2005 ; 310 : 1960-3.
- 10. Fruci D, Lauvau G, Saveanu L, et al. Quantifying recruitment of cytosolic peptides for HLA class I presentation : impact of TAP transport. J Immunol 2003 ; 170 : 2977-84.
- 11. Princiotta MF, Finzi D, Qian SB, et al. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 2003 ; 18 : 343-54.
- 12. Schwab SR, Shugart JA, Horng T, et al. Unanticipated antigens : translation initiation at CUG with leucine. PLoS Biol 2004 ; 2 : e366.
- 13. Vigneron N, Stroobant V, Chapiro J, et al. An antigenic peptide produced by peptide splicing in the proteasome. Science 2004 ; 304 : 587-90.
- 14. Ciechanover A. The ubiquitin-proteasome pathway : on protein death and cell life. EMBO J 1998 ; 17 : 7151-60.
- 15. Kloetzel PM. Generation of major histocompatibility complex class I antigens : functional interplay between proteasomes and TPPII. Nat Immunol 2004 ; 5 : 661-9.
- 16. Kisselev AF, Akopian TN, Woo KM, Goldberg AL. The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation. J Biol Chem 1999 ; 274 : 3363-71.
- 17. Reits E, Neijssen J, Herberts C, et al. A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation. Immunity 2004 ; 20 : 495-506.
- 18. Saric T, Graef CI, Goldberg AL. Pathway for degradation of peptides generated by proteasomes : a key role for thimet oligopeptidase and other metallopeptidases. J Biol Chem 2004 ; 279 : 46723-32.
- 19. Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994 ; 39 : 93-8.
- 20. van Endert PM, Saveanu L, Hewitt EW, Lehner P. Powering the peptide pump : TAP crosstalk with energetic nucleotides. Trends Biochem Sci 2002 ; 27 : 454-61.
- 21. Momburg F, Neefjes JJ, Hämmerling G. Peptide selection by MHC-encoded TAP transporters. Curr Opin Immunol 1994 ; 6 : 32-7.
- 22. Van Endert PM, Riganelli D, Greco G, et al. The peptide-binding motif for the human transporter associated with antigen processing. J Exp Med 1995 ; 182 : 1883-95.
- 23. Rock KL, York IA, Goldberg AL. Post-proteasomal antigen processing for major histocompatibility complex class I presentation. Nat Immunol 2004 ; 5 : 670-7.
- 24. Saveanu L, Carroll O, Lindo V, et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 2005 ; 6 : 689-97.
- 25. Chang SC, Momburg F, Bhutani N, Goldberg AL. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a « molecular ruler » mechanism. Proc Natl Acad Sci USA 2005 ; 102 : 17107-12.
- 26. Cresswell P, Bangia N, Dick T, Diedrich G. The nature of the MHC class I peptide loading complex. Immunol Rev 1999 ; 172 : 21-8.
- 27. Saveanu L, van Endert P. Dendritic cells : open for presentation business. Nat Immunol 2005 ; 6 : 7-8.
- 28. Desjardins M. ER-mediated phagocytosis : a new membrane for new functions. Nat Rev Immunol 2003 ; 3 : 280-91.
- 29. Touret N, Paroutis P, Terebiznik M, et al. Quantitative and dynamic assessment of the contribution of the ER to phagosome formation. Cell 2005 ; 123 : 157-70.
- 30. Lizee G, Basha G, Tiong J, et al. Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain. Nat Immunol 2003 ; 4 : 1065-73.